Preclinical studies of a PARP-targeted theranostic radiopharmaceutical for pancreatic cancer.

Front Pharmacol · 2025 · PMC12119578 · PMID 40444043

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Cell uptake of 177 Lu-DOTA-PEG-PARPi As shown in Figure 4 , cellular uptake also showed an increasing trend with the increase in time, reaching the maximum at 48 h.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.